Invention Grant
- Patent Title: Drug formulations
- Patent Title (中): 药物配方
-
Application No.: US14241635Application Date: 2012-08-29
-
Publication No.: US09381207B2Publication Date: 2016-07-05
- Inventor: Rajashree Joshi-Hangal , Chunlin Tang , Sanjeev Redkar , Harish Ravivarapu
- Applicant: Rajashree Joshi-Hangal , Chunlin Tang , Sanjeev Redkar , Harish Ravivarapu
- Applicant Address: US CA Pleasanton
- Assignee: ASTEX PHARMACEUTICALS, INC.
- Current Assignee: ASTEX PHARMACEUTICALS, INC.
- Current Assignee Address: US CA Pleasanton
- Agency: Wilson Sonsini Goodrich & Rosati
- International Application: PCT/US2012/052816 WO 20120829
- International Announcement: WO2013/033176 WO 20130307
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70 ; A61K31/708 ; A61K31/706 ; A61K31/7056 ; A61K31/7064 ; A61K31/7052 ; A61K31/7084 ; A61K9/00 ; A61K47/10 ; A61K47/20 ; A61K9/19
Abstract:
The invention provides derivatives of decitabine with superior chemical stability and shelf life, with similar physiological activity. The derivatives are provided in a non-aqueous formulation, which further stabilizes the derivatives. Methods of treating one or more myelodysplastic syndromes, leukemia, or solid tumors using the formulations are described.
Public/Granted literature
- US20140303107A1 DRUG FORMULATIONS Public/Granted day:2014-10-09
Information query
IPC分类:
